ResMed Inc. (BVMF:R1MD34)

Market Cap	197.64B
Revenue (ttm)	28.02B
Net Income (ttm)	7.66B
Shares Out	n/a
EPS (ttm)	52.07
PE Ratio	25.79
Forward PE	21.82
Dividend	2.11 (0.63%)
Ex-Dividend Date	Nov 12, 2025

Volume	1
Average Volume	38
Open	334.35
Previous Close	337.53
Day's Range	334.35 - 334.35
52-Week Range	302.75 - 397.00
Beta	0.87
RSI	41.77
Earnings Date	Jan 22, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: R1MD34

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD